MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV; BSX: COV), a leading global provider of healthcare products, today confirmed the immediate availability of its new and improved Magellan™ Safety Hypodermic Needle. The modified design, which is now shipping to all customers, is in stock and available at all Covidien distribution centers in the United States. Beginning today, the previous needle model is no longer being produced or sold.
